This case presentation discusses a 17-year-old male patient who presented with two episodes of seizures, vomiting, headache, unconsciousness, abnormal talking, and tightness in the limbs. Based on examination findings of perinatal hypoxia, mild cerebral atrophy, and abnormal EEG and brain mapping, the patient was diagnosed with primary generalized symptomatic seizures, auditory processing disorder, and mild mental retardation. The treatment plan included sodium valproate, ondansetron, cefotaxime, lorazepam, and noscapine. The goals of treatment were to control seizure frequency and minimize side effects to allow for a normal life. The patient was counseled on medication adherence, a healthy diet including

1. CASE PRESENTATION ON
Case Presented By
R . Naveen
13CD1T0025
III Pharm.D
1
Narasaraopeta Institute Of Pharmaceutical Sciences,
Narasaraopet.
Seizures
1

2. 2
Subjective
Objective
Assessment
Plan
Discharge medication
Treatment goals
Patient counseling

3. SUBJECTIVE
1. Age : 17 years.
2. Sex : Male
3. DOA : 09/10/15
4. C/O : Sudden onset of Episode Seizures , 2 episodes of
Vomiting , headache, unconscious about 15 mins , Abnormal
talking, tightness of both upper and lower limbs, Gastritis.
5. Past illness: fever with cold and cough since one week back.
6. Past medication : paracetamol , Citrizine.
7. Social history : middle class
3

4. OBJECTIVE:(VITALS)
DAY 1 DAY 2 DAY 3
 B.P-
130/90mm of
Hg
 P.R – 102
B/min
 Spo2 : 100%
 Temp:
Normal
 B.P-
110/70mm
of Hg
 P.R – 96
B/min
 Spo2 : 98%
 Temp:
Normal
4
 B.P-
120/80mm of
Hg
 P.R – 74
B/min
 Spo2 : 100%
 Temp:
Normal

5. 5
 Perinatal hypoxia
 Mild diffusable cerebral atrophy
Polyp in the left maxillary sinus

6. 6
 EEG and Brain map analysis includes
Intermittent spike and sharp discharge

7. 7
Assessment:
From the above subjective and objective
evidences finally diagnosed as
Primary generalized symptomatic
seizure
A P D – Auditory Processing Disorder
Mild MR

8. PLAN:
S.NO DRUG GENERIC
NAME
DOSE FREQUN
CY
DURATIO
N
01. Inj.Encorate Sodium valproate 5cc in
100ml
NS
IV/BID 1,2,3
02. Inj.Pantin Pantoprazole 40mg IV/OD 1,2,3
03. Inj.Zofer Ondansteron 2cc IV/BID 1,2,3
04. Inj.Taxim Cefotaxime 1gm IV/BID 1,2,3
05. Inj.Lorazepam Benzodiazepine 2mg in
10ml
06. Syp.Coscopin Noscapine 5ml Orally/BID 1,2,3
8

9. 9
DISCHARGE MEDICATION:
Tab. Rabeprazole 20 mg OD
 Tab .Sodium Valproate 500 mg OB
 Tab. Syradin OD

10. PHARMACEUTICAL CARE PLAN:
 Seizures
 Mild MR
 ADP
 Gliosis in the bilateral
periprolandic regions more
on right side likely to
perinatal hypoxia
 Ventricular system is dilated
 mild diffusable cerebral
atrophy
SUBJECTIVE OBJECTIVE
10

11. FINAL DIAGONSIS
 From the above subjective and objective evidence
the final diagonsed as
 Primary generalised Seizures
11

12. TREATMENT GOALS
 The goals of treatments is to control or reduce
the frequency of seizures and minimize side
effects
 Allowing the patient to live as normal a life as
possible
12

13. 13
PATIENT COUNSELLING:
 Take the Medication as per the Prescription.
 Take the Healthy Diet properly. (ketogenic diet)
 Exercise regularly.

14. REFERENCES
 A TEXT BOOK OF PHARMACO THERAPY BY
BARBARA G. WELLS JOSEPH T. DIPIRO
TERRY L. SCHWINGHAMMER CECILY V.
DIPIRO.
 US GUIDELINES
 CIMS BOOK 2015 .
14

15. 15